Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Cytel and Baxter extend xenotransplantation agreement

Feb. 5, 1998

CBER completes review of Thymoglobulin PLA

Feb. 2, 1998

OspC-based Lyme disease vaccine proves effective in animal model of chronic disease

Feb. 2, 1998

Aquila receives milestone payment from SKB under Stimulon agreement

Jan. 30, 1998

Another SMART antibody advances to clinical testing

Jan. 30, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

Chesapeake Biological Laboratories and LXR to codevelop Cardiosol products

Jan. 27, 1998

Nabi's Altastaph enters phase I/II

Jan. 26, 1998

Quilimmune-P enters phase II

Jan. 23, 1998

IL-12 offers new approach to BMT in leukemia patients

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...